Medtronic has received US Food and Drug Administration (FDA) 510 (k) clearance for its MiniMed Go Smart MDI system, a ...
The MiniMed Go™ system is cleared for individuals with insulin-requiring type 1 and type 2 diabetes aged 7 years and older, ...
Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily ...
Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with ...
The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S ...
Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Medtronic PLC has received approval to sell a device for diabetes patients that displays insulin levels on Internet-enabled devices and sends text messages to loved ones if something goes wrong. At an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback